Decipher Biosciences, Inc.;The Regents of the University of Michigan
发明人:
DAVICIONI, Elai,ERHO, Nicholas George,LEHRER, Jonathan,FENG, Felix Y.,ZHAO, Shuang G.
申请号：
AU2018310987
公开号：
AU2018310987A1
申请日:
2018.08.02
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Methods, systems, and kits for the diagnosis, prognosis and the determination of cancer progression of prostate cancer in a subject are disclosed. In particular, the disclosure relates to the use of immune cell-specific gene expression in determining prognosis and identifying individuals in need of treatment for prostate cancer who will be responsive to radiation therapy.
